Skip to main content
SpringerLink
Log in

Ambulatory Blood Pressure Phenotypes and the Risk for Hypertension

  • Prevention of Hypertension: Public Health Challenges (P Muntner, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Ambulatory blood pressure (BP) monitoring provides valuable information on a person’s BP phenotype. Abnormal ambulatory BP phenotypes include white-coat hypertension, masked hypertension, nocturnal nondipping, nocturnal hypertension, and high BP variability. Compared to people with sustained normotension (normal BP in the clinic and on ambulatory BP monitoring), the limited research available suggests that the risk of developing sustained hypertension (abnormal BP in the clinic and on ambulatory BP monitoring) over 5 to 10 years is approximately two to three times greater for people with white-coat or masked hypertension. More limited data suggest that nondipping might predate hypertension, and no studies, to our knowledge, have examined whether nocturnal hypertension or high ambulatory BP variability predict hypertension. Ambulatory BP monitoring may be useful in identifying people at increased risk of developing sustained hypertension, but the clinical utility for such use would need to be further examined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Go AS, Mozaffarian D, Roger VL, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410. doi:10.1161/01.cir.0000442015.53336.12. Presents the most recent statistics on cardiovascular disease including the contributions of hypertension.

    Article  PubMed  Google Scholar 

  2. Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the Multi-ethnic Study of Atherosclerosis. Hypertension. 2011;57:1101–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287(8):1003–10.

    Article  PubMed  Google Scholar 

  4. Whelton PK, He J, Appel LJ, National High Blood Pressure Education Program Coordinating Committee, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288(15):1882–8.

    Article  PubMed  Google Scholar 

  5. Sacks FM, Svetkey LP, Vollmer WM, DASH-Sodium Collaborative Research Group, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344(1):3–10.

    Article  PubMed  CAS  Google Scholar 

  6. Chobanian AV, Bakris GL, Black HR, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72.

    Article  PubMed  CAS  Google Scholar 

  7. Viera AJ, Lingley K, Esserman D. Effects of labeling patients as prehypertensive. J Am Board Fam Med. 2010;23(5):571–83.

    Article  PubMed  Google Scholar 

  8. Viera AJ, Bangura F, Mitchell CM, Cerna A, Sloane P. Do clinicians tell patients they have prehypertension? J Am Board Fam Med. 2011;24(1):117–8.

    Article  PubMed  Google Scholar 

  9. Spruill TM, Feltheimer SD, Harlapur M, et al. Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life. J Psychosom Res. 2013;74(5):433–8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Echouffo-Tcheugui JB, Batty GD, Kivimäki M, Kengne AP. Risk models to predict hypertension: a systematic review. PLoS ONE. 2013;8(7):e67370. This article provides a review of the available hypertension risk models and scores.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. N Engl J Med. 2006;354:2368–74.

    Article  PubMed  CAS  Google Scholar 

  12. O’Brien E, Parati G, Stergiou G, European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–68. doi:10.1097/HJH.0b013e328363e964. Presents comprehensive, up-to-date information on all aspects of ambulatory blood pressure monitoring.

    PubMed  Google Scholar 

  13. Pierdomenico SD, Di Nicola M, Esposito AL, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens. 2009;22(8):842–7.

    Article  PubMed  Google Scholar 

  14. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54(2):226–32. This article provides some of the leading evidence of the risk of sustained hypertension for people with white-coat and masked hypertension.

    Article  PubMed  CAS  Google Scholar 

  15. Ugajin T, Hozawa A, Okhubo T, et al. White-coat hypertension as a risk factor for the development of home hypertension. Arch Intern Med. 2005;165:1541–6.

    Article  PubMed  Google Scholar 

  16. Trudel X, Milot A, Brisson C. Persistence and progression of masked hypertension: a 5-year prospective study. Int J Hypertens. 2013;2013:836387. doi:10.1155/2013/836387. This article examines what happens to blood pressure in people identified with masked hypertension 5 years later.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Pierdomenico SD, Pannarale G, Rabbia F, et al. Prognostic relevance of masked hypertension in subjects with prehypertension. Am J Hypertens. 2008;21(8):879–83.

    Article  PubMed  Google Scholar 

  18. Viera AJ, Zhu S, Hinderliter AL, Shimbo D, Person SD, Jacobs Jr DR. Diurnal blood pressure pattern and development of prehypertension or hypertension in young adults: the CARDIA study. J Am Soc Hypertens. 2011;5(1):48–55.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Li Y, Wang J. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension. 2013;61:278–83.

    Article  PubMed  CAS  Google Scholar 

  20. Tsioufis C, Andrikou I, Thomopoulos C, Syrseloudis D, Stergiou G, Stefanadis C. Increased nighttime blood pressure or nondipping profile for prediction of cardiovascular outcomes. J Hum Hypertens. 2011;25:281–93.

    Article  PubMed  CAS  Google Scholar 

  21. Mena L, Pintos S, Queipo NV, Jaizpúrua JA, Maestre G, Sulbarán T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–11.

    Article  PubMed  CAS  Google Scholar 

  22. Stolarz-Skrzypek K, Thijs L, Li Y, et al. Short-term blood pressure variability in relation to outcome in the International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO). Acta Cardiol. 2011;66(6):701–6.

    PubMed  Google Scholar 

  23. Yamaguchi Y, Wada M, Sato H, et al. Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese. Am J Hypertens. 2014. A recent study of the association of ambulatory blood pressure variability with cognitive outcomes.

  24. Verberk WJ, Kessesl AG, de Leeuw PW. Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens. 2008;21:969–75.

    Article  PubMed  Google Scholar 

  25. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–8.

    Article  PubMed  CAS  Google Scholar 

  26. Brguljan-Hitij J, Thijs L, Li Y, Hansen TW, on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcome Investigators, et al. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014. Uses the large IDACO database to examine outcomes across different BP phenotypes.

  27. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508–15.

    Article  PubMed  Google Scholar 

  28. Viera AJ, Lin FC, Tuttle LA, Olsson E, Stankevitz K, Girdler SS, et al. Reproducibility of masked hypertension among adults 30 years or older. Blood Press Monit. 2014.

  29. Krause T, Lovibond K, Caulfield M, McCormack T, Williams B, Guideline Development Group. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. doi:10.1136/bmj.d4891.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Anthony Viera has served on the medical advisory board for Suntech Medical, manufacturer of a brand of ambulatory blood pressure monitor, as well as the hypertension advisory board for Daiichi-Sankyo.

Daichi Shimbo declares that he has no conflict of interest.

This article was partially supported by grants R01-HL098604 (Dr. Viera) and P01-HL047540 (Dr. Shimbo) from the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH).

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, USA

    Anthony J. Viera

  2. Hypertension Research Program, University of North Carolina at Chapel Hill, Chapel Hill, USA

    Anthony J. Viera

  3. Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, NY, USA

    Daichi Shimbo

  4. Department of Family Medicine, University of North Carolina at Chapel Hill, 590 Manning Drive, CB 7595, Chapel Hill, NC, 27599, USA

    Anthony J. Viera

Authors
  1. Anthony J. Viera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daichi Shimbo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony J. Viera.

Additional information

This article is part of the Topical Collection on Prevention of Hypertension: Public Health Challenges

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Viera, A.J., Shimbo, D. Ambulatory Blood Pressure Phenotypes and the Risk for Hypertension. Curr Hypertens Rep 16, 481 (2014). https://doi.org/10.1007/s11906-014-0481-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-014-0481-5

Keywords

Search

Navigation